Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04533217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 3, 2024 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jan 2024 to Jul 31, 2025
    • Study completion date: Jan 2024 to Jul 31, 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2021 to Mar 29, 2021
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).
Trial Details
NCT Number NCT04533217
Lead Sponsor Spine Centre of Southern Denmark
Conditions
(from sponsor)		 Vertebral Fracture, Multiple Myeloma
Related terms Multiple Myeloma, Spinal Fractures
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov